Cargando…

Gut microbiota signatures in Schistosoma japonicum infection-induced liver cirrhosis patients: a case–control study

BACKGROUND: Several studies have assessed the role of gut microbiota in various cirrhosis etiologies, however, none has done so in the context of Schistosoma japonicum infection in humans. We, therefore, sought to determine whether gut microbiota is associated with S. japonicum infection-induced liv...

Descripción completa

Detalles Bibliográficos
Autores principales: Gui, Qi-Feng, Jin, Hui-Lin, Zhu, Feng, Lu, Hai-Feng, Zhang, Qin, Xu, Jia, Yang, Yun-Mei, Xiao, Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004463/
https://www.ncbi.nlm.nih.gov/pubmed/33771232
http://dx.doi.org/10.1186/s40249-021-00821-8
_version_ 1783671913839591424
author Gui, Qi-Feng
Jin, Hui-Lin
Zhu, Feng
Lu, Hai-Feng
Zhang, Qin
Xu, Jia
Yang, Yun-Mei
Xiao, Chi
author_facet Gui, Qi-Feng
Jin, Hui-Lin
Zhu, Feng
Lu, Hai-Feng
Zhang, Qin
Xu, Jia
Yang, Yun-Mei
Xiao, Chi
author_sort Gui, Qi-Feng
collection PubMed
description BACKGROUND: Several studies have assessed the role of gut microbiota in various cirrhosis etiologies, however, none has done so in the context of Schistosoma japonicum infection in humans. We, therefore, sought to determine whether gut microbiota is associated with S. japonicum infection-induced liver cirrhosis. METHODS: From December 2017 to November 2019, 24 patients with S. japonicum infection-induced liver cirrhosis, as well as 25 age- and sex-matched controls from the Zhejiang Province, China, were enrolled. Fecal samples were collected and used for 16S rRNA gene sequencing (particularly, the hypervariable V4 region) using the Illumina MiSeq system. Wilcoxon Rank-Sum and PERMANOVA tests were used for analysis. RESULTS: Eight hundred and seven operational taxonomic units (OTUs) were detected, of which, 491 were common between the two groups, whereas 123 and 193 were unique to the control and cirrhosis groups, respectively. Observed species, Chao, ACE, Shannon, Simpson, and Good’s coverage indexes, used for alpha diversity analysis, showed values of 173.4 ± 63.8, 197.7 ± 73.0, 196.3 ± 68.9, 2.96 ± 0.57, 0.13 ± 0.09, and 1.00 ± 0.00, respectively, in the control group and 154.0 ± 68.1, 178.6 ± 75.1, 179.9 ± 72.4, 2.68 ± 0.76, 0.19 ± 0.18, and 1.00 ± 0.00, respectively, in the cirrhosis group, with no significant differences observed between the groups. Beta diversity was evaluated by weighted UniFrac distances, with values of 0.40 ± 0.13 and 0.40 ± 0.11 in the control and cirrhosis groups, respectively (P > 0.05). PCA data also confirmed this similarity (P > 0.05). Meanwhile, the relative abundance of species belonging to the Bacilli class was higher in cirrhosis patients [median: 2.74%, interquartile range (IQR): 0.18–7.81%] than healthy individuals (median: 0.15%, IQR: 0.47–0.73%; P < 0.01), and that of Lactobacillales order was also higher in cirrhosis patients (median: 2.73%, IQR: 0.16–7.80%) than in healthy individuals (median: 0.12%, IQR: 0.03–0.70%; P < 0.05). CONCLUSIONS: Cumulatively, our results suggest that the gut microbiota of S. japonicum infection-induced liver cirrhosis patients is similar to that of healthy individuals, indicating that bacterial taxa cannot be used as non-invasive biomarkers for S. japonicum infection-induced liver cirrhosis. [Image: see text]
format Online
Article
Text
id pubmed-8004463
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80044632021-03-30 Gut microbiota signatures in Schistosoma japonicum infection-induced liver cirrhosis patients: a case–control study Gui, Qi-Feng Jin, Hui-Lin Zhu, Feng Lu, Hai-Feng Zhang, Qin Xu, Jia Yang, Yun-Mei Xiao, Chi Infect Dis Poverty Research Article BACKGROUND: Several studies have assessed the role of gut microbiota in various cirrhosis etiologies, however, none has done so in the context of Schistosoma japonicum infection in humans. We, therefore, sought to determine whether gut microbiota is associated with S. japonicum infection-induced liver cirrhosis. METHODS: From December 2017 to November 2019, 24 patients with S. japonicum infection-induced liver cirrhosis, as well as 25 age- and sex-matched controls from the Zhejiang Province, China, were enrolled. Fecal samples were collected and used for 16S rRNA gene sequencing (particularly, the hypervariable V4 region) using the Illumina MiSeq system. Wilcoxon Rank-Sum and PERMANOVA tests were used for analysis. RESULTS: Eight hundred and seven operational taxonomic units (OTUs) were detected, of which, 491 were common between the two groups, whereas 123 and 193 were unique to the control and cirrhosis groups, respectively. Observed species, Chao, ACE, Shannon, Simpson, and Good’s coverage indexes, used for alpha diversity analysis, showed values of 173.4 ± 63.8, 197.7 ± 73.0, 196.3 ± 68.9, 2.96 ± 0.57, 0.13 ± 0.09, and 1.00 ± 0.00, respectively, in the control group and 154.0 ± 68.1, 178.6 ± 75.1, 179.9 ± 72.4, 2.68 ± 0.76, 0.19 ± 0.18, and 1.00 ± 0.00, respectively, in the cirrhosis group, with no significant differences observed between the groups. Beta diversity was evaluated by weighted UniFrac distances, with values of 0.40 ± 0.13 and 0.40 ± 0.11 in the control and cirrhosis groups, respectively (P > 0.05). PCA data also confirmed this similarity (P > 0.05). Meanwhile, the relative abundance of species belonging to the Bacilli class was higher in cirrhosis patients [median: 2.74%, interquartile range (IQR): 0.18–7.81%] than healthy individuals (median: 0.15%, IQR: 0.47–0.73%; P < 0.01), and that of Lactobacillales order was also higher in cirrhosis patients (median: 2.73%, IQR: 0.16–7.80%) than in healthy individuals (median: 0.12%, IQR: 0.03–0.70%; P < 0.05). CONCLUSIONS: Cumulatively, our results suggest that the gut microbiota of S. japonicum infection-induced liver cirrhosis patients is similar to that of healthy individuals, indicating that bacterial taxa cannot be used as non-invasive biomarkers for S. japonicum infection-induced liver cirrhosis. [Image: see text] BioMed Central 2021-03-26 /pmc/articles/PMC8004463/ /pubmed/33771232 http://dx.doi.org/10.1186/s40249-021-00821-8 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Gui, Qi-Feng
Jin, Hui-Lin
Zhu, Feng
Lu, Hai-Feng
Zhang, Qin
Xu, Jia
Yang, Yun-Mei
Xiao, Chi
Gut microbiota signatures in Schistosoma japonicum infection-induced liver cirrhosis patients: a case–control study
title Gut microbiota signatures in Schistosoma japonicum infection-induced liver cirrhosis patients: a case–control study
title_full Gut microbiota signatures in Schistosoma japonicum infection-induced liver cirrhosis patients: a case–control study
title_fullStr Gut microbiota signatures in Schistosoma japonicum infection-induced liver cirrhosis patients: a case–control study
title_full_unstemmed Gut microbiota signatures in Schistosoma japonicum infection-induced liver cirrhosis patients: a case–control study
title_short Gut microbiota signatures in Schistosoma japonicum infection-induced liver cirrhosis patients: a case–control study
title_sort gut microbiota signatures in schistosoma japonicum infection-induced liver cirrhosis patients: a case–control study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004463/
https://www.ncbi.nlm.nih.gov/pubmed/33771232
http://dx.doi.org/10.1186/s40249-021-00821-8
work_keys_str_mv AT guiqifeng gutmicrobiotasignaturesinschistosomajaponicuminfectioninducedlivercirrhosispatientsacasecontrolstudy
AT jinhuilin gutmicrobiotasignaturesinschistosomajaponicuminfectioninducedlivercirrhosispatientsacasecontrolstudy
AT zhufeng gutmicrobiotasignaturesinschistosomajaponicuminfectioninducedlivercirrhosispatientsacasecontrolstudy
AT luhaifeng gutmicrobiotasignaturesinschistosomajaponicuminfectioninducedlivercirrhosispatientsacasecontrolstudy
AT zhangqin gutmicrobiotasignaturesinschistosomajaponicuminfectioninducedlivercirrhosispatientsacasecontrolstudy
AT xujia gutmicrobiotasignaturesinschistosomajaponicuminfectioninducedlivercirrhosispatientsacasecontrolstudy
AT yangyunmei gutmicrobiotasignaturesinschistosomajaponicuminfectioninducedlivercirrhosispatientsacasecontrolstudy
AT xiaochi gutmicrobiotasignaturesinschistosomajaponicuminfectioninducedlivercirrhosispatientsacasecontrolstudy